{"version":"1.0","provider_name":"MedCity INVEST PharmaTech","provider_url":"https:\/\/events.medcitynews.com\/invest-pharmatech","author_name":"eclements","author_url":"https:\/\/events.medcitynews.com\/invest-pharmatech\/author\/eclements\/","title":"Richard Snyder, M.D. - MedCity INVEST PharmaTech","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"boC40TM224\"><a href=\"https:\/\/events.medcitynews.com\/invest-pharmatech\/speakers\/richard-snyder-m-d\/\">Richard Snyder, M.D.<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/events.medcitynews.com\/invest-pharmatech\/speakers\/richard-snyder-m-d\/embed\/#?secret=boC40TM224\" width=\"600\" height=\"338\" title=\"&#8220;Richard Snyder, M.D.&#8221; &#8212; MedCity INVEST PharmaTech\" data-secret=\"boC40TM224\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/events.medcitynews.com\/invest-pharmatech\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/events.medcitynews.com\/uploads\/sites\/3\/2016\/06\/Snyder_use.jpg","thumbnail_width":200,"thumbnail_height":200,"description":"Richard Snyder, M.D. is the senior vice president and chief medical officer at Independence Blue\u00a0Cross (IBC). In this role, he is the company\u2019s chief clinical spokesperson, and he has overall\u00a0corporate responsibility for medical, quality and pharmacy management, and all clinical policies\u00a0and programs. Dr. Snyder currently leads IBC\u2019s efforts to improve the quality of patient care&hellip;"}